4//SEC Filing
GALECTIN THERAPEUTICS INC 4
Accession 0000914062-13-000201
$GALTCIK 0001133416operating
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 5:16 PM ET
Size
5.3 KB
Accession
0000914062-13-000201
Insider Transaction Report
Form 4
MCGAULEY THOMAS
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2013-06-19+25,000→ 25,000 totalExercise: $3.97Exp: 2023-06-19→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The options vest in full on the first business day following the date that the Issuer files its Form 10-Q for the quarter ended June 30, 2013.
Documents
Issuer
GALECTIN THERAPEUTICS INC
CIK 0001133416
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001133416
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 5:16 PM ET
- Size
- 5.3 KB